Financial Year |
March 31 2023 |
Monetary Funds |
790,064,666.23 |
Held-for-trading Financial Assets |
397,589,178.85 |
Notes Receivable |
301,456,950.15 |
Accounts Receivable |
743,737,858.47 |
Advances to Suppliers |
10,160,415.59 |
Other Receivables |
31,296,477.38 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
515,636,086.80 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
45,420,566.34 |
Total Current Assets |
2,941,235,390.02 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
41,551,660.76 |
Fixed Assetes |
710,868,730.62 |
Under-construction Projects |
21,187,000.73 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
155,904,460.54 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
3,269,754.40 |
Deferred Income Tax Assets |
26,220,575.93 |
Other Non-Current Assets |
670,735.93 |
Sub-Total of Non-Current Assets |
2,419,984,746.92 |
Total Assets |
5,361,220,136.94 |
Short-Term Loans |
114,942,700.07 |
Trading Financial liabilities |
-- |
Notes Payable |
558,774,169.68 |
Accounts Payable |
699,135,778.54 |
Accounts Received In Advance |
888,392.59 |
Employee Compensation Payable |
21,728,474.64 |
Taxes Payable |
8,066,555.78 |
Interest Payable |
-- |
Dividend Payable |
3,891,433.83 |
Other payables |
158,783,513.56 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
84,601,814.24 |
Sub-Total of Current Liabilities |
1,683,299,959.63 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
180,560,050.46 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
216,765,676.40 |
Total Liabilities |
1,900,065,636.03 |
Paid-In Capital(Or Share Stock) |
705,692,507.00 |
Capital Surplus |
640,133,963.01 |
Surplus Reserve |
349,197,725.72 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
939,430,501.89 |
Minority Stockholder's Interest |
74,358,542.47 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,386,795,958.44 |
Owner's Equity(Stockholder's Equity) |
3,461,154,500.91 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,361,220,136.94 |